Stockreport

Verastem: An Undervalued Rare Oncology Gem With Big Upcoming Catalysts [Seeking Alpha]

Verastem, Inc.  (VSTM) 
Last verastem, inc. earnings: 10/29 04:17 pm Check Earnings Report
US:NASDAQ Investor Relations: verastem.com
PDF Verastem: An Undervalued Rare Oncology Gem With Big Upcoming CatalystsSummaryDuvelisib CLL/SLL (Chronic Lymphotic Leukemia/Small Lymphotic Leukemia) FDA priority review [Read more]